Physician profile
Armando Wayne Slack
NPI 1659572949
$8,066.36
in general payments reported to CMS, 2019-2025
15 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,935 · 2022: $1,634 · 2023: $173 · 2024: $853 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.95 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $5,625.75 | 2021-2025 | Aristada, Aristada Initio, Lybalvi |
| Abbvie INC. | $955.83 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $732.30 | 2022-2025 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $274.06 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Eisai INC. | $118.83 | 2021 | |
| Biogen, INC. | $89.02 | 2025 | Zurzuvae |
| Indivior INC. | $72.39 | 2022-2024 | Perseris |
| Teva Pharmaceuticals USA, INC. | $56.26 | 2022-2023 | Austedo |
| Corium, LLC | $28.82 | 2024 | Azstarys |
| Janssen Scientific Affairs, LLC | $23.78 | 2025 | Invega Sustenna |
| Takeda Pharmaceuticals U.S.A., INC. | $21.85 | 2025 | Trintellix |
| Sunovion Pharmaceuticals INC. | $19.43 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.57 | 2023 | |
| Noven Therapeutics, LLC | $15.02 | 2024 | Xelstrym |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Slack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.